| 产品名称: | Gallid herpesvirus 3 |
|---|---|
| 商品货号: | TS150069 |
| Classification: | Herpesviridae, Mardivirus |
| Deposited As: | Mareks disease virus type 2 |
| Agent: | Gallid herpesvirus 3 |
| Strain: | SB |
| Applications: | NOTE: This material is cited in a U.S. and/or other Patent Application and may not be used to infringe the patent claims. Will protect against MDV and non-virus producing JM tumor transplant. |
| Biosafety Level: | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation: | chicken (S-strain) peripheral blood lymphocytes |
| Product Format: | frozen |
| Storage Conditions: | xa0Vapor phase of liquid nitrogen |
| Disclosure: | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Comments: | Nononcogenic, cell associated. Will protect against MDV and non-virus producing JM tumor transplant. NOTE: This material is cited in a U.S. and/or other Patent Application and may not be used to infringe the patent claims. |
| Effect on Host: | xa0CPE, cell rounding and syncytia formation |
| Recommended Host: | chicken embryo fibroblasts |
| Growth Conditions: | Temperature: 37°C Incubation: xa0Incubate infected culture for 7 days at 37°C in a humidified 5% CO2 atmosphere, until CPE are well advance throughout. |
| Name of Depositor: | BW Calnek |
| U.S. Patent: | |
| U.S. Patent Number: | |
| Source: | chicken (S-strain) peripheral blood lymphocytes |
| References: | Schat KA, Calnek BW. Characterization of an apparently nononcogenic Mareks disease. J. Natl. Cancer Inst. 60: 1075-1082, 1978. PubMed: 76680 |